Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
NCT04241367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420
Last updated 2026-04-09
Summary
This study is for verification of predictive biomarkers for pancreatic cancer treatment using multi-center liquid biopsy.
Conditions
- Pancreas Adenocarcinoma
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
Sangmyung Woo, MD · National Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-28
- Primary Completion
- 2021-06-03
- Completion
- 2025-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
NCT04466189 ·Status: ENROLLING_BY_INVITATION
-
Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer
NCT04110769 ·Status: UNKNOWN ·Phase: NA
-
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer
NCT04293497 ·Status: COMPLETED ·Phase: NA
-
Studying Biomarkers in Patients With Pancreatic Cancer
NCT00900003 ·Status: COMPLETED
-
Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid
NCT04777604 ·Status: NOT_YET_RECRUITING
-
Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer
NCT01396668 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Biomarkers for Early Detection of Pancreatic Cancer
NCT00897494 ·Status: COMPLETED
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 ·Status: UNKNOWN
-
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
NCT04447092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
RNA Precision Oncology in Advanced Pancreatic Cancer
NCT04476537 ·Status: TERMINATED ·Phase: NA
-
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00897832 ·Status: COMPLETED
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques
NCT05289895 ·Status: UNKNOWN
-
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
NCT05596370 ·Status: UNKNOWN
-
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
NCT04665947 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer
NCT07326150 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
NCT01458717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
NCT05776342 ·Status: RECRUITING
-
Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer
NCT05745415 ·Status: COMPLETED
-
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
NCT01593475 ·Status: COMPLETED ·Phase: PHASE2
-
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT07030348 ·Status: RECRUITING
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
NCT01333124 ·Status: TERMINATED ·Phase: PHASE2
-
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer
NCT04373928 ·Status: UNKNOWN ·Phase: NA